Elizabeth Anne Pomfret

Elizabeth Anne Pomfret

Auto-generated profile, based on publicly available information

Elizabeth Anne Pomfret

University of Colorado School of Medicine

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2024 in American Journal of Transplantation
Verified
Journal Article
Open access
SBSyed Shahyan Bakhtiyar
Syed Shahyan Bakhtiyar
TMTiffany E. Maksimuk
Tiffany E. Maksimuk
JGJohn Gutowski
John Gutowski
SPSarah Y. Park
Sarah Y. Park
MCMichael T. Cain
Michael T. Cain
JHJordan R.H. Hoffman
Jordan R.H. Hoffman
Donation after circulatory death(DCD) could account for the largest expansion of the donor allograft pool in the contemporary era. However, the organ yield and associated costs of Normothermic Regional Perfusion(NRP) compared to Super-Rapid Recovery(SRR) with ex-situ Normothermic Machine Perfusion(NMP), remain unreported. The Organ Procurement and Transplantation Network (December 2019-June 2023) was analyzed to determine the number of organs recovered per donor. A cost analysis was performed based on our institution's experience since 2022. Of 43,502 donors, 30,646(70%) were Donors after Brain Death(DBD), 12,536(29%) DCD-SRR and 320(0.7%) DCD-NRP. The mean number of organs recovered was 3.70 for DBD, 3.71 for DCD-NRP(P<0.001), and 2.45 for DCD-SRR(P<0.001). Following risk-adjustment, DCD-NRP(AOR 1.34,CI 1.04-1.75) and DCD-SRR(AOR 2.11,CI 2.01-2.21;Reference:DBD) remained associated with greater odds of allograft non-use. Including incomplete and completed procurement runs, the total average cost of DCD-NRP was $9,463.22 per donor. By conservative estimates, we found that approximately 31 donor allografts could be procured using DCD-NRP for the cost equivalent of one allograft procured via DCD-SRR with ex-situ NMP. In conclusion, DCD-SRR procurements were associated with the lowest organ yield compared to other procurement methods. To facilitate broader adoption of DCD procurement, a comprehensive understanding of the trade-offs inherent in each technique is imperative.

19 July 2024 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
JHJordan R.H. Hoffman
Jordan R.H. Hoffman
MHMatthew G. Hartwig
Matthew G. Hartwig
MCMichael T. Cain
Michael T. Cain
JRJessica Y. Rove
Jessica Y. Rove
ASAleem Siddique
Aleem Siddique
PCPedro A. Catarino
Pedro A. Catarino

6 March 2023 in Liver Transplantation
Verified
Journal Article
Closed access
IZIoannis A. Ziogas
Ioannis A. Ziogas
CKChristos Kakos
Christos Kakos
DMDimitrios P. Moris
Dimitrios P. Moris
CKChristof Kaltenmeier
Christof Kaltenmeier
Georgios TsoulfasGeorgios Tsoulfas
Georgios Tsoulfas
EPElizabeth A. Pomfret
Elizabeth A. Pomfret
The value of minimally invasive approaches for living donor hepatectomy remains unclear. Our aim was to compare the donor outcomes after open versus laparoscopy-assisted versus pure laparoscopic versus robotic living donor hepatectomy (OLDH vs. LALDH vs. PLLDH vs. RLDH). A systematic literature review of the MEDLINE, Cochrane Library, Embase, and Scopus databases was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement (up to December 8, 2021). Random-effects meta-analyses were performed separately for minor and major living donor hepatectomy. The risk of bias in nonrandomized studies was assessed using the Newcastle-Ottawa Scale. A total of 31 studies were included. There was no difference in donor outcomes after OLDH versus LALDH for major hepatectomy. However, PLLDH was associated with decreased estimated blood loss, length of stay (LOS), and overall complications versus OLDH for minor and major hepatectomy, but also with increased operative time for major hepatectomy. PLLDH was associated with decreased LOS versus LALDH for major hepatectomy. RLDH was associated with decreased LOS but with increased operative time versus OLDH for major hepatectomy. The scarcity of studies comparing RLDH versus LALDH/PLLDH did not allow us to meta-analyze donor outcomes for that comparison. There seems to be a marginal benefit in estimated blood loss and/or LOS in favor of PLLDH and RLDH. The complexity of these procedures limits them to transplant centers with high volume and experience. Future studies should investigate self-reported donor experience and the associated economic costs of these approaches.

23 October 2017 in Liver Transplantation
Verified
Journal Article
Closed access
PDF file
KCKendra D. Conzen
Kendra D. Conzen
EPElizabeth A. Pomfret
Elizabeth A. Pomfret

28 February 2025 in Transplantation Direct
Verified
Journal Article
Open access
YBYanik J. Bababekov
Yanik J. Bababekov
AHAnna H. Ba Ha
Anna H. Ba Ha
TNTrevor L. Nydam
Trevor L. Nydam
CGCarlos Goncalves
Carlos Goncalves
RCRashikh Choudhury
Rashikh Choudhury
JPJames J. Pomposelli
James J. Pomposelli
Background.: Donation after circulatory death liver transplantation (DCD LT) is underused given historical outcomes fraught with ischemic cholangiopathy (IC). We aimed to assess 6-mo IC in LT from DCD via normothermic regional perfusion (NRP) compared with DCD via static cold storage (SCS). Methods.: A retrospective review of adult Maastricht-III DCD liver donors and recipients at the University of Colorado Hospital from January 1, 2017, to August 27, 2024, was performed. The 6-mo IC rate was compared between NRP and SCS. Secondary outcomes included biochemical assessments of accepted versus declined NRP liver allografts and allograft and patient survival for NRP and SCS groups. Results.: One hundred sixty-two DCD LTs (SCS = 79; NRP = 97) were performed and 150 recipients (SCS = 74; NRP = 86) reached 6-mo follow-up. Six-month IC was lower for NRP compared with SCS (1.2% versus 9.5%, P = 0.03). The Donor Risk Index (2.44 [2.02–2.82] versus 2.17 [1.97–2.30], P = 0.002) and UK DCD Risk Score (4.2 ± 2.9 versus 3.2 ± 2.3, P = 0.008) were higher for NRP versus SCS. The Liver Graft assessment Following Transplantation score was less for NRP compared with SCS (–3.3 versus –3.1, P < 0.05). There were several differences in median biochemical parameters during NRP between accepted and declined livers, including higher terminal biliary bicarbonate (22.7 [20.9–29.1] versus 10.8 [7.6–13.1] mEq/L, P = 0.004). There were no significant differences in 12-mo allograft or patient survival for NRP versus SCS. Conclusions.: NRP is a disruptive innovation that improves the utilization of DCD livers. Despite higher-risk donor-recipient pairing for NRP compared with SCS, we demonstrate a decrease in IC for NRP. These data facilitate benchmarking of thoracoabdominal NRP DCD LT and support further protocol development.